Athena Licenses Genetic Test for Intellectual Disability | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Athena Diagnostics, a subsidiary of Thermo Fisher Scientific, has licensed from Toronto's Centre for Addiction and Mental Health the rights to develop a test for intellectual disability based on CC2D2A gene mutations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.